Akili, Inc. (AKLI)
NASDAQ: AKLI · IEX Real-Time Price · USD
0.245
+0.009 (3.81%)
At close: Apr 26, 2024, 3:59 PM
0.242
-0.003 (-1.31%)
After-hours: Apr 26, 2024, 5:32 PM EDT
Akili Market Cap
Akili has a market cap or net worth of $19.26 million as of April 26, 2024. Its market cap has decreased by -81.18% in one year.
Market Cap
19.26M
Enterprise Value
-40.71M
1-Year Change
-81.18%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since June 30, 2021, Akili's market cap has decreased from $258.80M to $19.26M, a decrease of -92.56%. That is a compound annual growth rate of -60.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 19.10M | -2.05% |
Apr 24, 2024 | 19.50M | 3.72% |
Apr 23, 2024 | 18.80M | 4.44% |
Apr 22, 2024 | 18.00M | -3.74% |
Apr 19, 2024 | 18.70M | 2.75% |
Apr 18, 2024 | 18.20M | 8.98% |
Apr 17, 2024 | 16.70M | -5.65% |
Apr 16, 2024 | 17.70M | -1.67% |
Apr 15, 2024 | 18.00M | -12.62% |
Apr 12, 2024 | 20.60M | 1.98% |
Apr 11, 2024 | 20.20M | 4.12% |
Apr 10, 2024 | 19.40M | 1.04% |
Apr 9, 2024 | 19.20M | -5.88% |
Apr 8, 2024 | 20.40M | 5.15% |
Apr 5, 2024 | 19.40M | -3.00% |
Apr 4, 2024 | 20.00M | 1.01% |
Apr 3, 2024 | 19.80M | -2.94% |
Apr 2, 2024 | 20.40M | -6.85% |
Apr 1, 2024 | 21.90M | -3.95% |
Mar 28, 2024 | 22.80M | - |
Mar 27, 2024 | 22.80M | -23.75% |
Mar 26, 2024 | 29.90M | 29.44% |
Mar 25, 2024 | 23.10M | 7.94% |
Mar 22, 2024 | 21.40M | -6.55% |
Mar 21, 2024 | 22.90M | 7.01% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Streamline Health Solutions | 20.00M |
NeurAxis | 19.78M |
American Shared Hospital Services | 19.75M |
Alterity Therapeutics | 19.73M |
Vincerx Pharma | 19.20M |
FSD Pharma | 19.11M |
Talphera | 19.01M |
Indaptus Therapeutics | 18.61M |